Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

8.29USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$8.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
103,087
52-wk High
$8.29
52-wk Low
$2.54

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $170.63
Shares Outstanding(Mil.): 41.42
Dividend: --
Yield (%): --

Financials

BRIEF-Fate Therapeutics announces issuance of U.S. patent covering use of viral transduction enhancers in gene therapy

* Fate Therapeutics announces issuance of U.S. patent covering use of viral transduction enhancers in gene therapy

16 Aug 2017

BRIEF-Fate Therapeutics Q2 ‍net loss per common share $0.23​

* Fate Therapeutics reports second quarter 2017 financial results

15 Aug 2017

Earnings vs. Estimates